Tradestie Institutional Equity Comparison Engine
NEOG vs WGS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NEOG Overall Edge
NEOG Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Neogen Corp (NEOG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NEOG trades at 36.3x Forward P/E with -0.8% operating margin (+6.5% YoY revenue) versus WGS at 40.6x Forward P/E and -13.7% operating margin (+5.4% YoY). In options structure, NEOG sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro) against WGS sits in BREAKDOWN (21st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NEOG
NEOG 36.3x vs WGS 40.6x Fwd P/E
Growth & Margin Winner
NEOG
Op Margin -0.8% vs -13.7% ยท YoY +6.5% vs +5.4%
Momentum & Technical Winner
NEOG
1Y +70.8% vs -60.9% ยท 52W Pos 62% vs 14%
Options & Structure Winner
NEOG
CONSOLIDATION (25th %ile IV) vs BREAKDOWN (21st %ile IV)
NEOG
NASDAQ
Neogen Corp
In Vitro & In Vivo Diagnostic Substances
$10.88
-3.12% 1D
Market Cap
$2.5B
1M Return
-7.87%
1Y Return
+70.8%
Forward P/E
36.3x
Unified AI Score
43.0 / 100
HOLD
Tech 23.0
Fund 46.0
Flow 61.0
Mom 64.0
WGS
NASDAQ
GeneDx Holdings Corp. Class A Common Stock
Services-Health Services
$51.02
-2.58% 1D
Market Cap
$1.6B
1M Return
-19.79%
1Y Return
-60.86%
Forward P/E
40.6x
Unified AI Score
49.5 / 100
HOLD
Tech 33.0
Fund 53.0
Flow 70.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NEOG +70.8%
WGS -60.86%
Spread: +131.66 pp (NEOG Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NEOG Revenue | WGS Revenue | NEOG Op. Margin | WGS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $410M | $200M | 16.4% | -15.5% | NEOG |
| FY2020 | $420M | $180M | 16.1% | -134.9% | NEOG |
| FY2021 | $470M | $210M | 15.8% | -210.3% | NEOG |
| FY2022 | $530M | $230M | 11.1% | -284.5% | NEOG |
| FY2023 | $820M | $200M | 4.6% | -89.2% | NEOG |
| FY2024 | $920M | $310M | 6.3% | -7.6% | NEOG |
| FY2025 | $890M | $430M | -118.6% | -3.1% | WGS |
| FY2026 | $870M | N/A | -2.5% | N/A | NEOG |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NEOG | WGS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.5B | $1.6B | Larger Scale | NEOG |
| Trailing P/E Ratio Valuation | 16.0x | 38.8x | Lower Multiple | NEOG |
| Forward P/E Ratio Valuation | 36.3x | 40.6x | Lower Multiple | NEOG |
| Revenue Growth (YoY) Growth | +6.5% | +5.4% | Higher Growth | NEOG |
| Operating Margin (TTM) Profitability | -0.8% | -13.7% | Higher Margin | NEOG |
| Net Profit Margin Profitability | -6.3% | -24.1% | Higher Margin | NEOG |
| Return on Equity (ROE) Capital Efficiency | -2.7% | -41.4% | Higher ROE | NEOG |
| 52-Week Range Position Momentum | 62% ($5โ$14) | 14% ($32โ$171) | Stronger Trend | NEOG |
| Beta / 30D Volatility Risk Regime | 1.41ฮฒ ยท 40% Vol | 1.74ฮฒ ยท 111% Vol | Lower Realized Risk | NEOG |
| Unified Institutional Score Composite Signal | 43.0 / 100 (HOLD) | 49.5 / 100 (HOLD) | Higher Composite | WGS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NEOG vs WGS Buy Guide
NEOG
CONSOLIDATION
39d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
25th %ile
IV Regime
Balanced (25thโ60th %ile)
WGS
BREAKDOWN
96d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
21st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NEOG nor WGS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.